Longterm efficacy and safety of onceweekly semaglutide for weight loss in patients without diabetes: A systematic review and metaanalysis of randomized controlled trials
Vargas EJ, Pesta CM, Bali A, Ibegbu E, Bazerbachi F, Moore RL, et al
doi: 10.1007/s12011-024-04064-0 136 XuXXuZYangBYiKHeFSunAet al
PMID: 41966639 Coutinho LFD et al
Research on Ozempic for weight loss Even though its not approved specifically for obesity or overweight, research shows that Ozempic can lead to significant weight loss, which is why some healthcare providers may prescribe it off-label
Increasing evidence indicates that PSC activation plays an important role in the progression of islet fibrosis in T2DM patients and animal models [7, 33, 34]